Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Cancer development is like natural selection, involving mutated cells and environmental factors.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Half-siblings with a rare skin condition improved with treatment for a fungal infection, but hair loss remained.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

Keratin proteins are crucial for healthy skin, but mutations can cause skin disorders with no effective treatments yet.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Testosterone is crucial for development, growth, and various body functions in mammals.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Adrenal disorders often cause high blood pressure in young people.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Keratinocyte cytokines and genetic variations influence the development of moles and skin pigmentation.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Different people show different symptoms for genetic diseases because of how sensitive their bodies are to small changes in important factors.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.